With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ...

Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.

A first-of-its-kind treatment center aimed at helping those living with or at risk of HIV is now open in Minneapolis.

A man who has lived with HIV for 12 years is part of a campaign to raise awareness of the stigma associated with the ...

The Michigan Department of Health and Human Services released its plan to reduce new HIV infections by 90% by 2030 on Monday.

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

Ending AIDS as a public health threat by 2030 is a real possibility, tantalizingly close. But the job is not yet done.

Atlanta is set to make history this Friday with the first-ever Kiki Exhibition Ball at City Hall, an event celebrating the ...

A second hospital in a county is to offer HIV and hepatitis tests to accident and emergency patients. The year-long project, ...

A collaborative effort by residents and moves to uphold human rights are key to eliminating HIV/Aids as a public health issue ...

The National AIDS Memorial has honored Dan Bernal, UCSF vice chancellor for community and government relations, for his ...